Hepatic iodothyronine deiodinase type 1 activity is decreased in two ΔF508 cystic fibrosis mouse models

Journal of Cystic Fibrosis

Volumn 3, Issue 2, 2004, Pages 125-128

  Klaren, Peter H M ^a   Looijmans, Pieter H A ^b,c  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Cystic fibrosis; Iodothyronine deiodinase type 1; Liver; Thyroid hormone

Indexed keywords

THYROXINE DEIODINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME ACTIVITY; GENOTYPE; HOMOZYGOTE; LIVER LEVEL; METABOLIC PARAMETERS; MOUSE; NONHUMAN; THYROID FUNCTION; WILD TYPE;

ANIMALS; CYSTIC FIBROSIS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; IODIDE PEROXIDASE; LIVER; MALE; MICE; MICE, INBRED CFTR; TRIIODOTHYRONINE;

EID: 3342975616     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2004.02.002     Document Type: Article

References (38)

1. De Luca F. Trimarchi F. Sferlazzas C. et al. Thyroid function in children with cystic fibrosis Eur. J. Pediatr. 138 1982 327-330
2. Azizi F. Cystic fibrosis: thyroid function and alpha fetoprotein N. Engl. J. Med. 295 1976-1381
3. Knöpfle G. Das Schilddrüsenhormonsystem bei Mukoviszidose Klin. Padiatr. 197 1985 481-488
4. Segall-Blank M. Vagenakis A.G. Shwachman H. Ingbar S.H. Braverman L.E. Thyroid gland function and pituitary TSH reserve in patients with cystic fibrosis J. Pediatr. 98 1981 218-222
5. Rosenlund M.L. Selekman J.A. Kim H.K. Kritchevsky D. Dietary essential fatty acids in cystic fibrosis Pediatrics 59 1977 428-432
6. Sack J. Blau H. Amado O. Katznelson D. Thyroid function in cystic fibrosis patients compared with healthy Israeli children Isr. J. Med. Sci. 19 1983 17-19
7. Köhrle J. Local activation and inactivation of thyroid hormones: the deiodinase family Mol. Cell. Endocrinol. 151 1999 103-119
8. Bianco A.C. Salvatore D. Gereben B. Berry M.J. Larsen P.R. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases Endocr. Rev. 23 2002 38-89
9. Engler D. Burger A.G. The deiodination of the iodothyronines and of their derivatives in man Endocr. Rev. 5 1984 151-184
10. Visser T.J. Pathways of thyroid hormone metabolism Acta Med. Austriaca 23 1996 10-16
11. + pumps: implications for contractility Am. J. Physiol. 274 1998 R864-R867
12. Muller A. Zuidwijk M.J. Simonides W.S. van Hardeveld C. Modulation of SERCA2 expression by thyroid hormone and norepinephrine in cardiocytes: role of contractility Am. J. Physiol. 272 1997 H1876-H1885
13. Beyer I.W. Karmali R. Demeester-Mirkine N. Cogan E. Fuss M.J. Muscle dysfunction in subclinical hypothyroidism J. Clin. Endocrinol. Metab. 83 1998-1823
14. Beyer I.W. Karmali R. Demeester-Mirkine N. Cogan E. Fuss M.J. Serum creatine kinase levels in overt and subclinical hypothyroidism Thyroid 8 1998 1029-1031
15. 4 replacement therapy Clin. Endocrinol. (Oxf.) 51 1999 237-242
16. Monzani F. Caraccio N. Siciliano G. Manca L. Murri L. Ferrannini E. Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism J. Clin. Endocrinol. Metab. 82 1997 3315-3318
17. Rodolico C. Toscano A. Benvenga S. Migliorato A. Vita G. Skeletal muscle disturbances may precede clinical and laboratory evidence of autoimmune hypothyroidism J. Neurol. 245 1998 555-556
18. de Meer K. Jeneson J.A.L. Gulmans V.A.M. van der Laag J. Berger R. Efficiency of oxidative work performance of skeletal muscle in patients with cystic fibrosis Thorax 50 1995 980-983
19. Davis P.B. di Sant'Agnese P.A. Cystic fibrosis: thyroid function and alpha fetaprotein. Reply N. Engl. J. Med. 295 1976-1382
20. van Doorninck J.H. French P.J. Verbeek E. et al. A mouse model for the cystic fibrosis ΔF508 mutation EMBO J. 14 1995 4403-4411
21. Colledge W.H. Abella B.S. Southern K.W. et al. Generation and characterization of a ΔF508 cystic fibrosis mouse model Nat. Genet. 10 1995 445-452
22. van der Heide S.M. Visser T.J. Everts M.E. Klaren P.H.M. Metabolism of thyroid hormones in cultured cardiac fibroblasts of neonatal rats J. Endocrinol. 172 2002 111-119
23. Lowry O.H. Rosebrough N.J. Farr A.L. Randall R.J. Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265-275
24. Ferguson G.A. Statistical analysis in psychology and education 1971 McGraw-Hill New York
25. Grubb B.R. Boucher R.C. Pathophysiology of gene-targeted mouse models for cystic fibrosis Physiol. Rev. 79 1999 S193-S214
26. Mason M.M. Morris J.S. Derenzy B.A. et al. Whole body analysis of the knockout gene mouse model for cystic fibrosis using thermal and fast neutron activation analysis J. Radioanal. Nucl. Chem. 236 1998 107-112
27. Nève J. Van Geffel R. Hanocq M. Molle L. Plasma and erythrocyte zinc, copper and selenium in cystic fibrosis Acta Paediatr. Scand. 72 1983 437-440
28. Winklhofer-Roob B.M. Tiran B. Tuchschmid P.E. van't Hof M.A. Shmerling D.H. Effects of pancreatic enzyme preparations on erythrocyte glutathione peroxidase activities and plasma selenium concentrations in cystic fibrosis Free Radic. Biol. Med. 25 1998 242-249
29. Stead R.J. Redington A.N. Hinks L.J. Clayton B.E. Hodson M.E. Batten J.C. Selenium deficiency and possible increased risk of carcinoma in adults with cystic fibrosis Lancet 2 1985 862-863
30. Ward K.P. Arthur J.R. Russell G. Aggett P.J. Blood selenium content and glutathione peroxidase activity in children with cystic fibrosis, coeliac disease, asthma, and epilepsy Eur. J. Pediatr. 142 1984 21-24
31. van Caillie-Bertrand M. de Biéville F. Neijens H. Kerrebijn K. Fernandes J. Degenhart H. Trace metals in cystic fibrosis Acta Paediatr. Scand. 71 1982 203-207
32. Lloyd-Still J.D. Ganther H.E. Selenium and glutathione peroxidase levels in cystic fibrosis Pediatrics 65 1980 1010-1012
33. Castillo R. Landon C. Eckhardt K. Morris V. Levander O. Lewiston N. Selenium and vitamin E status in cystic fibrosis J. Pediatr. 99 1981 583-585
34. Bates J.M. Spate V.L. Morris J.S. St. Germain D.L. Galton V.A. Effects of selenium deficiency on tissue selenium content, deiodinase activity, and thyroid hormone economy in the rat during development Endocrinology 141 2000 2490-2500
35. Beckett G.J. Beddows S.E. Morrice P.C. Nicol F. Arthur J.R. Inhibition of hepatic deiodination of thyroxine is caused by selenium deficiency in rats Biochem. J. 248 1987 443-447
36. Beckett G.J. Russell A. Nicol F. Sahu P. Wolf C.R. Arthur J.R. Effect of selenium deficiency on hepatic type I 5-iodothyronine deiodinase activity and hepatic thyroid hormone levels in the rat Biochem. J. 282 1992 483-486
37. 4-levels in children with low selenium state due to reduced type I iodothyronine 5′deiodinase activity? J. Trace Elem. Electrolytes Health Dis. 7 1993 53-55
38. Dworkin B. Newman L.J. Berezin S. Rosenthal W.S. Schwarz S.M. Weiss L. Low blood selenium levels in patients with cystic fibrosis compared to controls and healthy adults J. Parent Enter. Nutr. 11 1987 38-41